Delayed Graft Function clinical trials
The registry lists 76 studies for Delayed Graft Function across more than 10 countries. 12 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-25.
Status
- Completed
- 32
- Status unknown
- 14
- Terminated
- 10
- Recruiting
- 8
- Not yet recruiting
- 4
- Withdrawn
- 4
Phase
- Phase 2
- 22
- Phase 3
- 12
- Phase 4
- 12
- Phase 1
- 9
- Early Phase 1
- 1
Where
- United States
- 38
- Spain
- 12
- France
- 11
- Canada
- 10
- China
- 7
- Germany
- 7
Who runs them
Y's Therapeutics, Inc. (3) · Angion Biomedica Corp (3) · University of Wisconsin, Madison (3) · Quark Pharmaceuticals (2) · Prolong Pharmaceuticals (2) · Alexion Pharmaceuticals, Inc. (2) · King Chulalongkorn Memorial Hospital (1) · Third Affiliated Hospital, Sun Yat-Sen University (1)
Studies
Recruiting first, then most recently updated. Showing 50 of 76 — search for more.
- The Impact of Intraoperative Diuretic Use on Delayed Graft Function Following Deceased Donor Renal TransplantationRecruitingNCT07726134Not applicable1 country
- TxAccess and Dd-cfDNA for Improved Care of Patients With Delayed Graft FunctionNot yet recruitingNCT07825688Not applicable
- Ex Vivo Normothermic Perfusion in Kidney Transplantation.RecruitingNCT05175885Not applicable1 country
- Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney TransplantationRecruitingNCT06830798Phase 318 countries
- Microvasculature Ultrasound Super-resolution in Transplant Delayed Graft FunctionNot yet recruitingNCT076455991 country
- Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney TransplantationRecruitingNCT04005469Phase 1/21 country
- Deceased Donor Kidney Storage at 10 Celsius Versus Conventional StorageRecruitingNCT07385651Not applicable1 country
- The Effects of Vonoprazan Fumarate on DGF Incidence in DD Kidney Transplant RecipientsRecruitingNCT07275632Phase 1/21 country
- Preventing Delayed Graft Function in Kidney Transplant PatientsNot yet recruitingNCT06724211Not applicable1 country
- Intermittent Versus Continuous Surface O2 During HMP of DCD KidneysRecruitingNCT05430620Phase 31 country
- Norepinephrine Infusion Combined With Goal-directed Fluid Therapy in Patients Undergoing Kidney TransplantationsRecruitingNCT06367205Not applicable1 country
- Novel Cooling Device for the Elimination of Warm Ischemia During Renal TransplantationNot yet recruitingNCT05166460Not applicable1 country
- ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft FunctionActive, not recruitingNCT05907096Phase 211 countries
- Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults at High Risk of Delayed Graft Function (DGF) Following Kidney Allograft TransplantationWithdrawnNCT07020832Phase 31 country
- Furosemide Stress Test Predicting Early Graft Function in Kidney TransplantationCompletedNCT03071536Not applicable1 country
- Cyclosporine A Pretreatment and Kidney Graft FunctionCompletedNCT02907554Phase 41 country
- Effect of Terlipressin for Intraoperative Blood Pressure Management in Kidney TransplantationActive, not recruitingNCT06855758Not applicable1 country
- Contrast-Enhanced Ultrasound for Kidney TransplantTerminatedNCT02911714Phase 11 country
- Heme Arginate in Transplantation StudyTerminatedNCT03646344Phase 31 country
- Volatile Anesthetic Protection Of Renal Transplants 2CompletedNCT02727296Phase 44 countries
- Calcineurin Inhibitor in NEuRoloGically Deceased Donors to Decrease Kidney delaYed Graft Function (CINERGY)Active, not recruitingNCT05148715Phase 21 country
- Study of the Correlation Between Donor CIRBP and Transplanted Kidney FunctionCompletedNCT066416221 country
- Better Evidence for Selecting Transplant FluidsCompletedNCT03829488Phase 32 countries
- A Retrospective Cohort Study on Predicting Delayed Graft Function in Liver Transplant Patients with Hepatocellular Carcinoma: a Nomogram and Machine Learning Approaches.CompletedNCT066267241 country
- Graft Acute Kidney Injury: Vitamin B3 to Facilitate Renal Recovery In the Early Life of a TransplantCompletedNCT05513807Phase 31 country
- Reparixin in Prevention of Delayed Graft Function After Kidney TransplantationCompletedNCT00248040Phase 24 countries
- Envarsus in Delayed Graft Function (E-DGF)CompletedNCT03864926Phase 41 country
- Deceased Organ Donor Interventions to Protect Kidney Graft FunctionCompletedNCT02525510Not applicable1 country
- Tacrolimus to Sirolimus Conversion for Delayed Graft FunctionTerminatedNCT00931255Phase 41 country
- Belatacept for Renal Transplant Recipients With Delayed Graft FunctionTerminatedNCT02134288Early Phase 11 country
- Reduce the Severity of DGF in Recipients of a Deceased Donor KidneyStatus unknownNCT02474667Phase 31 country
- Belatacept Compared to Tacrolimus in Deceased Donor Renal Transplant RecipientsCompletedNCT02152345Phase 41 country
- RUCONEST® as a Therapeutic Strategy to Reduce the Incidence of Delayed Graft FunctionStatus unknownNCT03791476Phase 11 country
- Renaparin® in Kidney TransplantationCompletedNCT03773211Phase 11 country
- QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney TransplantCompletedNCT02610296Phase 311 countries
- Propensity Score Matched Comparison of HMP vs. SCS in Kidney TransplantationCompletedNCT043591731 country
- Deceased Donor Biomarkers and Recipient OutcomesCompletedNCT018482491 country
- Evaluation of CAF22 After Renal TransplantationCompletedNCT023469682 countries
- Efficacy, Safety, Tolerability and Pharmacokinetic (PK) Study of GSK1070806 for the Prevention of Delayed Graft Function (DGF) in Adult Subjects After Renal TransplantationTerminatedNCT02723786Phase 22 countries
- A Study of the Activity of Eculizumab for Prevention of Delayed Graft Function In Deceased Donor Kidney TransplantTerminatedNCT01403389Phase 21 country
- A Pilot Study Comparing the Safety and Efficacy of Everolimus With Other Medicines in Recipients of ECD/DCD KidneysTerminatedNCT01878786Phase 2/31 country
- Effect of Dexmedetomidine on Renal Function and Delayed Graft Function After Kidney TransplantationStatus unknownNCT03327389Not applicable1 country
- Prevention of Delayed Graft Function Using Eculizumab Therapy (PROTECT Study)CompletedNCT02145182Phase 2/39 countries
- Belatacept in Kidney Transplantation of Moderately Sensitized PatientsWithdrawnNCT02130817Phase 41 country
- Effects of Mannitol on Delayed Graft Function After Cadaveric Renal TransplantationCompletedNCT02705573Phase 31 country
- C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRICompletedNCT02134314Phase 1/21 country
- The Frequency and Risk Factors of Delayed Graft FunctionCompletedNCT03555513
- A Study on SANGUINATE™ for the Reduction of Delayed Graft Function in Kidney Transplant PatientsWithdrawnNCT02658162Phase 2
- Intra-graft Coagulation Events in Clinical Renal Transplantation and Delayed Graft FunctionStatus unknownNCT025686961 country
- Eculizumab for Prevention of Delayed Graft Function (DGF) in Kidney TransplantationTerminatedNCT01919346Phase 21 country